N. Dartois

发表

Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

S. Laurent, P. Boutouyrie, D. Hayoz, 2000, Circulation.

A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada

N. Qizilbash, S. Mcneil, N. Dartois, 2016, Canadian respiratory journal.

A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada.

N. Qizilbash, S. Mcneil, N. Dartois, 2015, Canadian respiratory journal.

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.

M. Beuran, A. Razbadauskas, N. Dartois, 2008, The Journal of antimicrobial chemotherapy.

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.

E. Loh, N. Dartois, T. Babinchak, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections - The European Experience

J. Tellado, Arthur J. L. Cooper, N. Dartois, 2008, Journal of chemotherapy.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

T. Welte, F. Blasi, A. Torres, 2018, Respiratory medicine.

Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

Arthur J. L. Cooper, J. Korth-Bradley, S. Bhavnani, 2011, Antimicrobial Agents and Chemotherapy.

[Local pulse pressure and regression of arterial wall hypertrophy during antihypertensive treatment. CELIMENE study. The Celiprolol Intima-Media Enalapril Efficacy study].

D. Hayoz, P. Boutouyrie, B. Laloux, 2000, Archives des maladies du coeur et des vaisseaux.

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

J. Strausz, C. Tanaseanu, N. Dartois, 2009, BMC pulmonary medicine.

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

J. Ramirez, J. Korth-Bradley, J. Yan, 2013, Antimicrobial Agents and Chemotherapy.

Tigecycline Versus Levofloxacin for the Treatment of Community-Acquired Pneumonia: European Experience

Arthur J. L. Cooper, N. Dartois, H. Gandjini, 2008, Journal of chemotherapy.

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

C. Tanaseanu, N. Dartois, G. Dukart, 2008, Diagnostic microbiology and infectious disease.

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

F. Blasi, A. Torres, M. Akova, 2015, Thorax.

PCVs in individuals at increased risk of pneumococcal disease: a literature review

N. Dartois, P. Balmer, M. Fletcher, 2015, Expert review of vaccines.

The Efﬁcacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial Data

E. Loh, N. Dartois, T. Babinchak, 2005 .

Tigecycline is efficacious in the treatment of complicated intra-abdominal infections.

M. Beuran, G. Barauskas, E. Loh, 2005, International journal of surgery.

Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.

Y. Chuang, Arthur J. L. Cooper, N. Dartois, 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Overview of Tigecycline Efficacy and Safety in the Treatment of Complicated Skin and Skin Structure Infections - A European Perspective

Arthur J. L. Cooper, J. Gardovskis, N. Dartois, 2008, Journal of chemotherapy.

Effect of celiprolol treatment in hypertensive patients with sleep apnea.

N. Dartois, C. Planès, B. Raffestin, 1999, Sleep.

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

E. Loh, J. Gardovskis, N. Dartois, 2005, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.

J. Korth-Bradley, J. Yan, N. Dartois, 2012, Clinical therapeutics.

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.

E. Loh, N. Dartois, T. Babinchak, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

Arthur J. L. Cooper, N. Dartois, T. Babinchak, 2008, The Journal of antimicrobial chemotherapy.

Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.

Arthur J. L. Cooper, J. Yan, N. Dartois, 2014, Diagnostic microbiology and infectious disease.

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.

Y. Chuang, J. Korth-Bradley, N. Dartois, 2010, Diagnostic microbiology and infectious disease.

Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination.

F. Blasi, A. Torres, P. Bonanni, 2017, European journal of internal medicine.

Treatment of Heart Failure With Celiprolol, a Cardioselective Beta Blocker With Beta-2 Agonist Vasodilatory Properties

A. Cohen-Solal, N. Dartois, S. Witchitz, 2000 .

Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.

A. Cohen-Solal, N. Dartois, S. Witchitz, 2000, The American journal of cardiology.

Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005-2010).

P. Casez, N. Dartois, J. Gaillat, 2015, Medecine et maladies infectieuses.

Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline

J. Korth-Bradley, S. Bhavnani, P. Ambrose, 2011, Antimicrobial Agents and Chemotherapy.

A retrospective study of hospitalized pneumonia in two Polish counties (2006-2008).

N. Dartois, Jian Ye, S. Gray, 2013, Pneumonologia i alergologia polska.

Send Orders of Reprints at Reprints@benthamscience.net Tigecycline versus Levofloxacin in Hospitalized Patients with Community-acquired Pneumonia: an Analysis of Risk Factors on Behalf of the 308 and 313 Study Groups

N. Dartois, C. A. Cooper, H. Gandjini, 2022 .

Hospital-Acquired Pneumonia Imipenem-Cilastatin for Treatment of Tigecycline Regimens versus Clinical Efficacy of Two High-Dosage Randomized Phase 2 Trial To Evaluate the

J. Ramirez, Jeany Q. Li, J. Korth-Bradley, 2013 .

Tigecycline Versus Levofloxacin in Hospitalized Patients With Community-Acquired Pneumonia: An Analysis of Risk Factors

N. Dartois, C. A. Cooper, H. Gandjini, 2013, The open respiratory medicine journal.